March 30, 2026

Privacy compliance vs assurance in clinical trials: Why you need both

Clinical research organisations are increasingly asked to demonstrate privacy assurance through recognised frameworks and certifications. For teams already navigating multiple regulatory requirements, this can quickly feel overwhelming.  Whilst compliance with laws such as the EU and UK General Data Protection Regulation (GDPR) or the US Health Insurance Portability and Accountability Act (HIPAA) remains essential, sponsors, partners, and regulators are now also looking for evidence that privacy and security controls operate effectively in practice. 
March 2, 2026

Clinical trials and GDPR: 5 common misconceptions and how to overcome them

In fast-moving clinical trial set-ups, General Data Protection Regulation (GDPR) governance and compliance can often seem like another layer of operational complexity. However, the challenge is rarely the regulation itself but uncertainty around how to interpret and apply it in practice. When expectations are not fully aligned across sponsors, CROs, and trial teams, this can increase risk and delay study timelines.
October 27, 2025

Pseudonymisation under the GDPR: What the latest EU ruling means for organisations

On 4 September, the Court of Justice of the European Union (CJEU) delivered an important judgement in European Data Protection Board (EDPS) vs Single Resolution Board (SRB), providing fresh clarification on the status of pseudonymised data under the EU General Data Protection Regulation (GDPR). 
June 9, 2025

Clinical trials part 3: GDPR considerations for Informed Consent Forms

In Part 3 of our clinical trials blog series, we explore the key GDPR considerations sponsors should address when preparing and localising Informed Consent Forms (ICFs). […]
May 12, 2025

Clinical trials part 2: Data protection considerations for vendor Data Processing Agreements

Data Processing Agreements (DPAs) are legally required under the EU and UK General Data Protection Regulation (GDPR) whenever clinical trial sponsors use third-party vendors to process […]
April 14, 2025

Clinical trials part 1: Data protection considerations for Clinical Trial Agreements

In this first part of our clinical trials blog series, we explore some of the key data protection considerations that sponsors need to cover in Clinical […]
September 16, 2024

How to choose the right lawful basis for clinical trial data processing

Clinical trial sponsors often face challenges when it comes to selecting the right lawful basis for clinical trial data processing. Key questions include whether the choice […]
July 24, 2023

Anonymisation Part 2: Risk Reduction for CROs, Sponsors & Partners Conducting Clinical Trials

Outlining risk reduction for CROs, sponsors & partners conducting clinical trials Clinical Trials are vital to the research and development cycle in life sciences organisations, and […]
July 19, 2023

Anonymisation Part 1: challenges & considerations for life sciences

  Introduction & anonymisation techniques Effective anonymisation is an issue for many organisations, however the process remains a crucial tool in safeguarding privacy rights and ensuring […]
November 28, 2022

What is the European Health Data Space and what does it mean for your organisation?

The European Health Data Space (EHDS) Regulation marks one of the most significant milestones in the EU’s data and digital health strategy to date. It is structured into two core areas: primary use for patients and secondary use for clinical trials and research.
Change your cookie consent